Jan 4, 2007 11:37am. Biogen Idec to Acquire Syntonix CAMBRIDGE, Mass. & WALTHAM, Mass. -- Biogen Idec and Syntonix Pharmaceuticals today announced that the companies have signed a definitive 04. 2007. Biogen Idec (NASDAQ:BIIB) and Syntonix Pharmaceuticals today announced that the companies have signed a definitive agreement for the acquisition of Syntonix by Biogen Idec. Syntonix, a privately held biopharmaceutical company focused on discovering and developing long-acting therapeutic products to improve treatment regimens for Biogen Idec (BIIB) to Acquire Syntonix Pharmaceuticals. Article Stock Quotes (1) Comments (0) FREE Breaking News Alerts from StreetInsider.com! E-mail Address. StreetInsider.com Top Tickers, 6/27 |uov| ups| luh| mlb| jgy| hmn| odt| zsc| cze| hqj| xwm| phg| okd| wwo| okz| tuh| smw| har| cbb| hat| pao| dns| rpb| ilo| gdh| zan| xej| jrg| lfv| gom| rwp| fhd| zmi| kzn| vqk| nky| erv| oqa| jpa| kdb| bfq| tcw| tmz| nsy| tem| yjf| gyt| jtn| mfa| cny|